Final results of CORE-001: A phase-2, single arm study of cretostimogene grenadenorepvec in combination with pembrolizumab in patients with BCG-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ

被引：0
|
作者：
Li, Roger
Shah, Paras H.
Stewart, Tyler F.
Bivalacqua, Trinity
Lamm, Donald L.
Geynisman, Daniel M.
Meeks, Joshua J.
Uchio, Edward M.
Jacob, Joseph M.
Dickstein, Rian J.
Pearce, Shane
Burke, James M.
Steinberg, Gary D.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[2] Mayo Clin Rochester, Rochester, MN USA
[3] Univ Calif San Diego, La Jolla, CA USA
[4] Univ Penn, Perelman Sch Med, Div Urol, Philadelphia, PA USA
[5] BCG Oncol, Phoenix, AZ USA
[6] Fox Chase Canc Ctr, Philadelphia, PA USA
[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL USA
[8] UCI Hlth, Orange, CA USA
[9] SUNY Upstate Med Univ, Syracuse, NY USA
[10] Chesapeake Urol, Hanover, MD USA
[11] Spokane Urol, Spokane, WA USA
[12] Billings Clin, Billings, MT USA
[13] Rush Univ, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4601
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
    Li, Roger
    Shah, Paras H.
    Stewart, Tyler F.
    Nam, Jong Kil
    Bivalacqua, Trinity J.
    Lamm, Donald L.
    Uchio, Edward M.
    Geynisman, Daniel M.
    Jacob, Joseph M.
    Meeks, Joshua J.
    Dickstein, Rian
    Pearce, Shane M.
    Kang, Seok Ho
    Jung, Seung Il
    Kamat, Ashish M.
    Burke, James M.
    Keegan, Kirk A.
    Steinberg, Gary D.
    NATURE MEDICINE, 2024, 30 (06)
  • [2] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Shore, Neal
    O'Donnell, Michael
    Keane, Thomas
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    Dickstein, Rian
    Wolk, Fred
    Dunshee, Curtis
    Belkoff, Laurence
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
  • [3] PHASE 3 STUDY OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: INITIAL RESULTS
    Dickstein, Rian
    Wu, Ning
    Cowan, Barrett
    Dunshee, Curtis
    Franks, Michael
    Wolk, Fred
    Belkoff, Laurence
    Castelucci, Sean
    Holzbeierlein, Jeffrey
    Kulkarni, Girish
    Weizer, Alon
    Lamm, Donald
    Brooks, David
    Epstein, Jonathon
    Ali, Syed
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1167 - E1167
  • [4] PHASE 3 STUDY OF VICINEUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER: 24-MONTH RESULTS
    O'Donnell, Michael
    Shore, Neal
    Keane, Thomas
    Jewett, Michael
    Dickstein, Rian
    Wolk, Fred
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2021, 206 : E296 - E297
  • [5] BOND-003-COHORT P: A MULTI-NATIONAL, SINGLE-ARM STUDY OF INTRAVESICAL CRETOSTIMOGENE GRENADENOREPVEC FOR THE TREATMENT OF HIGH-RISK, PAPILLARY ONLY, BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Mark, D. Tyson
    Woodson, W. Smelser
    Rian, J. Dickstein
    Daniel, E. Zainfeld
    Roger, Li
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [6] THE CRETOSTIMOGENE GRENADENOREPVEC EXPANDED ACCESS PROGRAM IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN
    Sarah, P. Psutka
    Sima, Porten
    Kristen, Scarpato
    Mary, Westerman
    Suzanne, Merrill
    Anne, Schuckman
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [7] Expanded access program of cretostimogene grenadenorepvec in patients with non-muscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin.
    Psutka, Sarah P.
    Porten, Sima P.
    Scarpato, Kristen R.
    Westerman, Mary E.
    Merrill, Suzanne B.
    Schuckman, Anne K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) : TPS902 - TPS902
  • [8] A phase 1/2 study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ
    Bryce, Richard
    Tosone, Christine
    Sullivan, James C.
    Linback, Tammy
    Steinberg, Gary D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Joffe, Benjamin I.
    Christin, John R.
    Le Coz, Clementine
    Pak, Jamie S.
    Laplaca, Caroline
    Reyes, Helena Vila
    DeCastro, G. Joel
    Anderson, Christopher B.
    Abate-Shen, Cory
    McKiernan, James M.
    Lenis, Andrew T.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E247 - E248
  • [10] CORE1: Phase 2 single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Steinberg, G. S.
    Uchio, E. U.
    Lamm, D. L.
    Shah, P. S.
    Kamat, A. K.
    Trinity, B.
    Packiam, V.
    Chisamore, M. C.
    Mcadory, J.
    Grandi, P.
    Hnat, N.
    Burke, J.
    EUROPEAN UROLOGY, 2023, 83 : S603 - S603
12345